- Research works
- 49 ▲ 596% vs 2013–17
- Citations
- 585 12.0 per fractional work
- Top-10% rate
- 12.2% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Pliant (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.2×. Every wedge is a field page.
- Immunology and Microbiology 10.2×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 3.0×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Dentistry 1.2×
- Agricultural and Biological Sciences 1.1×
- Chemistry 1.0×
- Health Professions 1.0×
- Economics, Econometrics and Finance 0.9×
- Neuroscience 0.6×
- Psychology 0.1×
- Computer Science 0.0×
- Engineering 0.0×
- Social Sciences 0.0×
Which keywords describe research at Pliant (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Fibrosis, Angiogenesis, Epithelial-Mesenchymal Transition, TGF-ß, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis and Myofibroblast.
- Management
- Fibroblast Activation Protein
- Chitin
- Immunosuppressive Therapy
- Prevention
- Diagnosis
- Tumor Microenvironment
- Immune Response
- Integrins
- Extracellular Matrix
- Myofibroblast
- Idiopathic Pulmonary Fibrosis
- Epithelial-Mesenchymal Transition
- Fibrosis
- Inflammation
- Angiogenesis
- TGF-ß
- Interstitial Lung Disease
- Cancer
- Cell Adhesion
- Epidemiology
- Cancer Therapy
- Biomarkers
- Metabolism
- Regulation
- Metastasis
- Enzymes
- Immunosuppression
- Pathogenesis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Inflammation7▲ 12×13 topics
- Fibrosis6▲ 112×3 topics
- Angiogenesis6▲ 61×6 topics
- Epithelial-Mesenchymal Transition6▲ 211×2 topics
- TGF-ß5▲ 125×2 topics
- Idiopathic Pulmonary Fibrosis5▲ 402×1 topic
- Interstitial Lung Disease5▲ 293×2 topics
- Myofibroblast5▲ 402×1 topic
- Cancer5▲ 13×10 topics
- Extracellular Matrix4▲ 71×2 topics
- Cell Adhesion3▲ 266×1 topic
- Integrins3▲ 468×1 topic
- Epidemiology2▲ 1.95×8 topics
- Immune Response2▲ 13×5 topics
- Cancer Therapy2▲ 11×5 topics
- Tumor Microenvironment2▲ 14×4 topics
- Biomarkers2▲ 9.0×5 topics
- Diagnosis1▲ 5.5×2 topics
- Metabolism1▲ 10×3 topics
- Prevention1▲ 12×2 topics
- Regulation1▲ 8.7×3 topics
- Immunosuppressive Therapy1▲ 24×3 topics
- Metastasis1▲ 13×5 topics
- Chitin1▲ 74×1 topic
- Enzymes1▲ 103×1 topic
- Fibroblast Activation Protein1▲ 90×1 topic
- Immunosuppression1▲ 43×1 topic
- Management1▲ 5.0×2 topics
- Pathogenesis1▲ 7.8×5 topics
Which research topics does Pliant (United States) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Cell Adhesion Molecules Research, Peptidase Inhibition and Analysis and Studies on Chitinases and Chitosanases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 5 works
- 2 Cell Adhesion Molecules Research Immunology and Allergy 3 works
- 3 Peptidase Inhibition and Analysis Oncology 1 works
- 4 Studies on Chitinases and Chitosanases Molecular Biology 1 works
- 5 Pediatric health and respiratory diseases Emergency Medical Services 1 works
- 6 Toxoplasma gondii Research Studies Parasitology 1 works
- 7 Liver Diseases and Immunity Hepatology 1 works
- 8 Platelet Disorders and Treatments Hematology 0 works
- 9 Toxin Mechanisms and Immunotoxins Immunology 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pliant (United States)'s research output changed?
Output in 2018–2022 was 596% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.